REPLIGEN CORPORATION

REPLIGEN CORPORATION is the sort of biotech supplier that matters most to drug makers and lab teams, especially when the job is purification, process equipment, and tools for biologics manufacturing. By our assessment, its strength is that it serves a real bottleneck in modern biomanufacturing rather than chasing consumer attention. The trade-off is that this is technical, capital-heavy work, so the company lives deep in a specialist supply chain and will never feel simple to outsiders. In practice, that usually means hardware, systems, and consumables that are noticed only when they work well. It sits in a serious industrial slice of biotech, closer to production infrastructure than to headline science. People building or running biologics processes have a reason to care; everyone else mostly sees a name that points to infrastructure, not a product on a shelf. The rating follows from that useful specialization and from the fact that the business is narrower than its industry buzz would suggest.